Scientists probe bone marrow to unlock secrets of childhood leukemia

NCT ID NCT05792007

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at bone marrow cells from children with acute leukemia and compares them to cells from children without blood diseases. The goal is to understand why some leukemias relapse or resist treatment. Researchers will measure how these cells use energy and handle stress, which may reveal new ways to fight the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could reveal why some children's leukemia resists treatment, pointing toward new drug targets.
What could go wrong
This is an early observational study with only 40 participants, so findings may not apply broadly or lead directly to new treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Service d'hématologie biologique-CHRU TOURS

    NOT_YET_RECRUITING

    Tours, 37044, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Service d'onco-hématologie pédiatrique -CHRU Tours

    RECRUITING

    Tours, 37044, France

    Contact

    Contact

    Contact

    Contact Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

  • Service de chirurgie orthopédique pédiatrique -CHRU TOURS

    RECRUITING

    Tours, 37044, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.